Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04913415

A Study to Evaluate Routine Chest Tube Management After Minimally Invasive Lung Surgery

Study to Evaluate a Low Suction (LS) Versus Standard Suction (SS) Strategy for Patients Undergoing Minimally Invasive Lung Resection by VATS or Robotic Approach

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Chest tubes are routinely required after surgical procedures for lung cancer. This device is a flexible plastic tube that is inserted through the chest wall to remove air or fluid from around your lungs after surgery for lung cancer. There are two general strategies associated with the clinical management of chest tubes, active and passive suction. If suction is compared to driving a car, active suction is similar to pressing the gas pedal while passive suction is like letting your car move on its own. The suction approach taken by surgeons largely depends on how they were trained and some personal biases and beliefs. However there is no general consensus about which chest tube management strategy is best. This research aims to compare two settings on a digital drainage system, a low suction (LS) mode - passive suction - and standard suction (ss) mode - active suction. From the data collected, the researchers will analyze whether LS or SS will lead to a better recovery after surgery.

Conditions

Interventions

TypeNameDescription
OTHERLow Suction Strategy of Chest Tube ManagementA digital chest tube will be set to a low pressure mode (-8mmHg) during recovery after minimally invasive lung resection.
OTHERStandard Suction Strategy of Chest Tube ManagementA digital chest tube will be to the standard suction mode (-20mmHg) during recovery after minimally invasive lung resection.

Timeline

Start date
2021-02-23
Primary completion
2024-08-01
Completion
2024-08-01
First posted
2021-06-04
Last updated
2024-04-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04913415. Inclusion in this directory is not an endorsement.